NEW YORK (GenomeWeb) – Mergers and acquisitions in the omics and molecular diagnostics space stayed soft through the first half of the year as the number of deals dropped 33 percent year over year.

Through the six months ending June 30, 16 M&A deals were either announced or completed, down from 24 in the first half of 2013. Sequentially, the drop was 30 percent from 23 deals in the second half of 2013.

The numbers include those transactions in which an entire company was acquired, but does not include the purchases of assets or divisions only.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.